Treatment outcomes in patients receiving combination antiretroviral therapy in Central Hospital, Benin City, Nigeria

Tropical Journal of Pharmaceutical Research

Volumn 9, Issue 1, 2010, Pages 1-10

  Agu, Kenneth A ^a   Ochei, Uche M ^a   Oparah, Azuka C ^a   Onoh, Obialunamma U ^a  

^a NONE

Author keywords

Antiretroviral therapy; HIV AIDS; Mortality; Nigeria; Therapy outcomes

Indexed keywords

CD4 ANTIGEN; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGERIA; PATIENT ASSESSMENT; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

EID: 77149134979     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v9i1.52028     Document Type: Article

References (17)

1. Federal Ministry of Health, FMOH. Technical Report, National HIV/Syphilis Sero-prevalence Sentinel Survey among Pregnant Women Attending Antenatal Clinics in Nigeria, 2005; 5-7.
2. Federal Ministry of Health, FMOH. Guidelines for the use of Antiretroviral (ARV) drugs in Nigeria. 2005; pp 25-47.
3. Ngwai YB, Odama LE. HIV/AIDS Prevention Services In: Skill Certification Workshop on HIV/AIDS, STIs, and Opportunistic Infections for Community Pharmacists, Participant's Manual June 2006; 5-6.
4. GHAINing Ground. A Newsletter from Global HIV/AIDS Initiative Nigeria, Family Health International, 2005; 1-4.
5. GHAINing Ground. A Newsletter from Global HIV/AIDS Initiative Nigeria, Family Health International. 2006; 2-5.
6. Family Health International. Update on Global HIV/AIDS initiative Nigeria (GHAIN), Focus on Edo state, Institute for HIV/AIDS, Arlington, USA. December 2006; 1-4.
7. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH. Clinical Outcomes and CD4-cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia. JAMA 2007; 298(16): 1888-1899.
8. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiam bo D, Mankhambo L. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, Lancet 2006; 367(9519): 1335-1342.
9. Corey DM, Kim HW, Salazar R, Illescas R, Villena J, Gutie rrez L, Sanchez J, Tabet SR. Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study. The Journal of Acquired Immune Deficiency Syndromes, 2007; 44(4): 451-455.
10. Sabin CA (2005). Baseline Characteristics Influence Benefits from Highly Active Antiretroviral Therapy. AIDS Journal, 2005; 19: pp 1995-2000.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
12. Praska JL, Kripalani S, Seright AL, Jacobsen TA. Identifying and assisting low-literacy patients with medication use: a survey of community pharmacies. Ann Pharmacother. 2005; 39: 1441-1445.
13. Vanhove GF, Schapiro JM, Winters MA. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 1996; 276: 1955-1956.
14. Deeks S, Beatty G, Cohen PT. Viral load and CD4+ T-cell changes in patients failing potent protease inhibitor therapy. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago. Abstract 419.
15. Montaner JS, Reiss P, Cooper D. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, the Netherlands, Canada, and Australia Study. JAMA 1998; 279: 930-937.
16. Melbourne KM., Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication Adherence in Patients with HIV Infection: A Comparison of Two Measurement Methods AIDS Journal. 1999; Read 9(5): 329-338.
17. Palella FJ, Deloria-Knoll M, Chmiel JS. Survival benefit of initiating antiretroviral therapy in HIVinfected persons in different CD4+ cell strata. Ann Intern Med 2003; 138(8): 620-626.